XML 30 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Note 11 - Stock-based Compensation
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

NOTE 11: STOCK-BASED COMPENSATION

 

A summary of outstanding options is included below:

 

Time Vesting Options

     

Weighted

             
      

Average

  

Weighted

      

Weighted

 
      

Remaining

  

Average

      

Average

 

Range of Exercise

 

Number

  

Contractual

  

Exercise

  

Options

  

Exercise

 

Prices between

 

Outstanding

  

Life

  

Price

  

Exercisable

  

Price

 

$4.01 - $8.00

  566,673   6.38  $7.42   566,673  $7.42 

$8.01+

  95,791   1.78   25.06   95,791  $25.06 
   662,464   5.72  $9.97   662,464     

 

Performance Vesting Options

         

Weighted

                         

 

 

         

Average

   

Weighted

           

Weighted

 
       

Remaining

   

Average

           

Average

 

Number

   

Contractual

   

Exercise

   

Options

   

Exercise

 

Outstanding

   

Life

   

Price

   

Exercisable

   

Price

 
  240,000       6.17     $ 7.59       240,000     $ 7.59  
  240,000       6.17     $ 7.59       240,000          

 

Market Vesting Options

         

Weighted

                         

 

 

 

         

Average

   

Weighted

           

Weighted

 
       

Remaining

   

Average

           

Average

 

Number

   

Contractual

   

Exercise

   

Options

   

Exercise

 

Outstanding

   

Life

   

Price

   

Exercisable

   

Price

 
  733,334       0.88     $ 3.00       -     $ -  
  733,334       0.88     $ 3.00       -          

 

                                   

Performance Vesting

 
   

Market Vesting Options

   

Time Vesting Options

   

Options

 
           

Weighted

           

Weighted

           

Weighted

 
           

Average

           

Average

           

Average

 
   

Options

   

Exercise

   

Options

   

Exercise

   

Options

   

Exercise

 

Date/Activity

 

Outstanding

   

Price

   

Outstanding

   

Price

   

Outstanding

   

Price

 

Balance, December 31, 2023

    733,334       3.00       662,798     $ 10.00       240,000     $ 7.59  

Granted

    -       -       -       -       -       -  

Forfeited or expired

    -       -       (334 )     71.10       -       -  

Balance, March 31, 2024

    733,334       3.00       662,464       9.97       240,000     $ 7.59  

 

The weighted average remaining contractual life for options exercisable is 5.84 years as of March 31, 2024.

 

Employee Awards

 

Stock-based compensation expense recognized for the issuance of stock options to employees for the three months ended March 31, 2024 and 2023 of $3 and $225, respectively, was included in general and administrative expense in the Condensed Consolidated Financial Statements. At  March 31, 2024, there was $12 of total unrecognized compensation expense related to unvested share-based awards with market vesting criteria for employees. Compensation expense related to market vesting options will be recognized over the next 11 months and will be adjusted for any future forfeitures as they occur.

 

Non-Employee Awards

 

Stock-based compensation expense recognized for the issuance of stock options to our non-employee Board of Directors, for the three months ended March 31, 2024 and 2023 was $0 and $43 and included in general and administrative expense in the Condensed Consolidated Financial Statements. At March 31, 2024, there was no unrecognized compensation expense related to share-based awards for non-employee directors.